IPHYF
Price
$2.90
Change
+$1.55 (+114.81%)
Updated
Dec 13 closing price
Capitalization
185.12M
KNBIF
Price
$0.07
Change
+$0.01 (+16.67%)
Updated
Feb 27 closing price
Capitalization
10.4M
Ad is loading...

IPHYF vs KNBIF

Header iconIPHYF vs KNBIF Comparison
Open Charts IPHYF vs KNBIFBanner chart's image
Innate Pharma
Price$2.90
Change+$1.55 (+114.81%)
Volume$1.65K
Capitalization185.12M
Kane Biotech
Price$0.07
Change+$0.01 (+16.67%)
Volume$24K
Capitalization10.4M
IPHYF vs KNBIF Comparison Chart
Loading...
View a ticker or compare two or three
VS
IPHYF vs. KNBIF commentary
Mar 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPHYF is a Hold and KNBIF is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 03, 2025
Stock price -- (IPHYF: $2.90 vs. KNBIF: $0.07)
Brand notoriety: IPHYF and KNBIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPHYF: 100% vs. KNBIF: 30%
Market capitalization -- IPHYF: $185.12M vs. KNBIF: $10.4M
IPHYF [@Biotechnology] is valued at $185.12M. KNBIF’s [@Biotechnology] market capitalization is $10.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $398.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.49B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPHYF’s FA Score shows that 0 FA rating(s) are green whileKNBIF’s FA Score has 0 green FA rating(s).

  • IPHYF’s FA Score: 0 green, 5 red.
  • KNBIF’s FA Score: 0 green, 5 red.
According to our system of comparison, both IPHYF and KNBIF are a bad buy in the long-term.

Price Growth

IPHYF (@Biotechnology) experienced а 0.00% price change this week, while KNBIF (@Biotechnology) price change was -11.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.98%. For the same industry, the average monthly price growth was -6.49%, and the average quarterly price growth was -2.51%.

Industries' Descriptions

@Biotechnology (-3.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
IPHYF($185M) has a higher market cap than KNBIF($10.4M). IPHYF YTD gains are higher at: 0.000 vs. KNBIF (-13.896).
IPHYFKNBIFIPHYF / KNBIF
Capitalization185M10.4M1,779%
EBITDAN/A-3.94M-
Gain YTD0.000-13.896-
P/E RatioN/A1.70-
RevenueN/A2.01M-
Total CashN/A544K-
Total DebtN/A2.28M-
FUNDAMENTALS RATINGS
IPHYF vs KNBIF: Fundamental Ratings
IPHYF
KNBIF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
41
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
90100
PRICE GROWTH RATING
1..100
3786
P/E GROWTH RATING
1..100
10073
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KNBIF's Valuation (41) in the null industry is in the same range as IPHYF (71). This means that KNBIF’s stock grew similarly to IPHYF’s over the last 12 months.

KNBIF's Profit vs Risk Rating (100) in the null industry is in the same range as IPHYF (100). This means that KNBIF’s stock grew similarly to IPHYF’s over the last 12 months.

IPHYF's SMR Rating (90) in the null industry is in the same range as KNBIF (100). This means that IPHYF’s stock grew similarly to KNBIF’s over the last 12 months.

IPHYF's Price Growth Rating (37) in the null industry is somewhat better than the same rating for KNBIF (86). This means that IPHYF’s stock grew somewhat faster than KNBIF’s over the last 12 months.

KNBIF's P/E Growth Rating (73) in the null industry is in the same range as IPHYF (100). This means that KNBIF’s stock grew similarly to IPHYF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GAB5.570.10
+1.83%
Gabelli Equity Trust (The)
DURA34.010.46
+1.37%
VanEck Durable High Dividend ETF
ETEC19.57N/A
N/A
iShares Breakthrough Envirtl Sol ETF
PGJ29.67-0.57
-1.88%
Invesco Golden Dragon China ETF
MSOS3.10-0.14
-4.32%
AdvisorShares Pure US Cannabis ETF

IPHYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHYF has been loosely correlated with ONPPF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHYF jumps, then ONPPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHYF
1D Price
Change %
IPHYF100%
N/A
ONPPF - IPHYF
41%
Loosely correlated
N/A
KNBIF - IPHYF
6%
Poorly correlated
N/A
INNMF - IPHYF
6%
Poorly correlated
N/A
IGXT - IPHYF
6%
Poorly correlated
N/A
OTLC - IPHYF
4%
Poorly correlated
N/A
More

KNBIF and

Correlation & Price change

A.I.dvisor tells us that KNBIF and CADL have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KNBIF and CADL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNBIF
1D Price
Change %
KNBIF100%
N/A
CADL - KNBIF
22%
Poorly correlated
+4.36%
LQDA - KNBIF
21%
Poorly correlated
+0.85%
SPHDF - KNBIF
20%
Poorly correlated
N/A
MMIRF - KNBIF
12%
Poorly correlated
N/A
IGXT - KNBIF
7%
Poorly correlated
N/A
More